ARCALION 200

ARCALION 200

Content Sulbutiamine.
Description Each tablet contains the following excipients: Maize starch, sodium carboxymethylcellulose, white beeswax, titanium dioxide, pregelatinized maize starch, ethylcellulose, anhydrous glucose, lactose, sunset yellow FCF, glyceryl mono-oleate, polysorbate 80, polyvidone excipient, saccharose, anhydrous colloidal silica, magnesium stearate and talc.
Actions Antiasthenic drug.

Pharmacology: In Animals: Pharmacological studies carried out in animals, either with acute or chronic administration, have evidenced the following actions: Sulbutiamine increases physical resistance to fatigue, neuromuscular efficiency and learning and memory; and improves the metabolic functions of the cerebral cortex.
In Man: The activity of sulbutiamine has been studied in functional asthenia in the course of controlled clinical studies (against placebo or reference products) using psychometric scales (Middlesex Hospital Questionnaire, Crocq Scale for the evaluation of nonpsychotic depressive conditions, Lipman auto-evaluation scale), with statistical analysis of the results. These studies showed the activity of sulbutiamine in the symptomatic treatment of functional asthenia.
Pharmacokinetics: Sulbutiamine is rapidly absorbed and the blood concentration is maximum in 1-2 hrs after oral administration. The molecule is rapidly distributed in the whole organism and is eliminated with a biological half-life of 5 hrs.
The urinary excretion is maximal 2-3 hrs after administration.
Indication   Symptomatic treatment of functional asthenia.
Dosage   Adult 2-3 tab daily.
Adverse Reaction     Occasionally: mild agitation in the elderly, allergic skin reactions.
Presentation & Packing

Form	Packing / Price	Photo
tab	200 mg x 100's